垂体腺瘤围术期糖皮质激素应用的研究进展  

Study Progress of Perioperative Glucocorticoid Application in Pituitary Adenoma

作　　者：韩祥福 伍敏[2] HAN Xiangfu;WU Min(Department of Pharmacy,Guizhou Provincial People's Hospital,Guiyang,Guizhou Province,550002 China;Department of Neurosurgery,Guizhou Provincial People's Hospital,Guiyang,Guizhou Province,550002 China)

机构地区：[1]贵州省人民医院药剂科,贵州贵阳550002 [2]贵州省人民医院神经外科,贵州贵阳550002

出　　处：《系统医学》2024年第10期194-198,共5页Systems Medicine

基　　金：黔科合基础-ZK[2022]一般261。

摘　　要：垂体腺瘤是颅内常见的一种神经内分泌肿瘤,当前对于该肿瘤的首选治疗方法是内镜经鼻蝶手术。因为垂体本身独特的神经内分泌器官属性,使得围术期维持垂体-靶腺功能稳定成为了关注的重点内容。长期以来,激素被作为重要的替代治疗方案应用在围术期。文中主要就针对垂体腺瘤围术期糖皮质激素应用的相关研究进行了综述,希望可以为垂体腺瘤围术期维持垂体-靶腺功能稳定提供有益借鉴。Pituitary adenoma is a common intracranial neuroendocrine tumor,and the current treatment of choice for this tumor is endoscopic transsphenoidal surgery.Because of the unique neuroendocrine organ properties of the pitu⁃itary gland,maintaining the pituitary-target gland functional stability in the perioperative period has become a key concern.Hormones have long been applied perioperatively as an important alternative treatment option.In this article,we mainly review the studies on the application of glucocorticoids in the perioperative period of pituitary adenomas,hoping to provide useful reference for maintaining the stability of pituitary-target gland function in the perioperative period of pituitary adenomas.

关 键 词：垂体腺瘤 围手术期 糖皮质激素 

分 类 号：R739.41[医药卫生—肿瘤]